Novartis AGNVSNYSE
Loading
Year-over-year operating income growth rate
Percentile
P13
Within normal range
vs 5Y Ago
-2.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -21.78% |
| Q3 2025 | -7.46% |
| Q2 2025 | 4.31% |
| Q1 2025 | 32.10% |
| Q4 2024 | -2.67% |
| Q3 2024 | -9.64% |
| Q2 2024 | 19.00% |
| Q1 2024 | 30.64% |
| Q4 2023 | 46.54% |
| Q3 2023 | -37.23% |
| Q2 2023 | 7.22% |
| Q1 2023 | 34.33% |
| Q4 2022 | 6.74% |
| Q3 2022 | -18.04% |
| Q2 2022 | -21.88% |
| Q1 2022 | 11.32% |
| Q4 2021 | -20.75% |
| Q3 2021 | -7.07% |
| Q2 2021 | 44.06% |
| Q1 2021 | -8.66% |
| Q4 2020 | 9.62% |
| Q3 2020 | 2.55% |
| Q2 2020 | -14.29% |
| Q1 2020 | 50.52% |
| Q4 2019 | -22.69% |
| Q3 2019 | -11.45% |
| Q2 2019 | 18.78% |
| Q1 2019 | 72.59% |
| Q4 2018 | -41.98% |
| Q3 2018 | -7.90% |
| Q2 2018 | 2.53% |
| Q1 2018 | 14.54% |
| Q4 2017 | -12.18% |
| Q3 2017 | 3.38% |
| Q2 2017 | 18.63% |
| Q1 2017 | 32.10% |
| Q4 2016 | -35.87% |
| Q3 2016 | 8.41% |
| Q2 2016 | -14.61% |
| Q1 2016 | 46.15% |